ADAPTHEALTH CORP AHCO 深 沪
交易中 10-01 10:18:05 美东时间
5.59
-0.050
-0.89%
华盛通- 最 高5.73
- 今 开5.65
- 成交量 8.74万股
- 最 低 5.585
- 昨 收 5.64
- 总市值 7.62亿
- 52周最高 13.43
- 市盈率 静 --
- 换手率 0.06%
- 52周最低 5.21
- 委 比 3.43%
- 总股本 1.36亿
- 历史最高 41.579
- 量 比 0.54
- 振 幅 2.57%
- 历史最低 5.21
- 每 手 1
- 风险率 1.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 赛富时获多家机构上调目标价，最高至300美元！谷歌获看多至450美元，仍有3成上涨空间
今日重点评级关注：Canaccord Genuity：维持Generac Holdings"买入"评级，目标价从275美元升至375美元；巴克莱：维持Oscar Health"超配"评级，目标价从39美元升至49美元
09-18 16:18
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.
09-17 20:07
AdaptHealth appoints new chief financial officer Currie
The latest update is out from AdaptHealth ( ($AHCO) ). AdaptHealth Corp. announ...
09-09 05:13
AdaptHealth appoints Harriss Currie as CFO
AdaptHealth (AHCO) said on Tuesday it appointed Harriss T. Currie as chief financial officer, effective Sept. 9. Currie will succeed Jason Clemens, who will assist with the transition through Oct. 1. ...
09-09 04:12
AdaptHealth Corp. Appoints Harriss T. Currie CFO, Effective Sept. 9, Succeeding Jason Clemens
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chi...
09-09 04:00
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
08-07 02:56
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
AdaptHealth 2026财年第二季度财报：营收增长但盈利承压
AdaptHealth 2026财年第二季度营收7.403亿美元，同比增长12.7%，持续经营每股亏损1.07美元；合同转换成本和制造商提价压低利润，公司同步下调全年调整后EBITDA指引。
08-05 06:53
UPDATE: AdaptHealth Q2 Adj. EPS $0.08 Misses $0.17 Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.17 by 52.94 percent. This is a 20 percent decrease over earnings of $0.10 per share from the same period last year.
08-04 21:12
AdaptHealth shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY26 sales guidance below estimates.
AdaptHealth shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY26 sales guidance below estimates.
08-04 20:37
